Verma, S.; Petrella, T.; Hamm, C.; Bak, K.; Charette, M.; the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline. Curr. Oncol. 2008, 15, 85-89.
https://doi.org/10.3747/co.v15i2.173
AMA Style
Verma S, Petrella T, Hamm C, Bak K, Charette M, the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline. Current Oncology. 2008; 15(2):85-89.
https://doi.org/10.3747/co.v15i2.173
Chicago/Turabian Style
Verma, S., T. Petrella, C. Hamm, K. Bak, M. Charette, and the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
2008. "Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline" Current Oncology 15, no. 2: 85-89.
https://doi.org/10.3747/co.v15i2.173
APA Style
Verma, S., Petrella, T., Hamm, C., Bak, K., Charette, M., & the members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
(2008). Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline. Current Oncology, 15(2), 85-89.
https://doi.org/10.3747/co.v15i2.173
